|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 182.12 AUD | -0.99% |
|
-1.84% | -35.34% |
| 09/12 | Shares of CSL Fall After Audit Office Statement on Unit's Vaccine Deal | MT |
| 09/12 | CSL's China Albumin Sale to Improve in Fiscal H2 2026, Says Jefferies | MT |
| Capitalization | 5.89TCr 5.02TCr 4.69TCr 4.41TCr 8.11TCr 5,33500Cr 8.86TCr 55TCr 21TCr 2,51500Cr 22TCr 22TCr 9,17900Cr | P/E ratio 2026 * |
23.3x | P/E ratio 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise value | 6.77TCr 5.77TCr 5.38TCr 5.06TCr 9.32TCr 6,12800Cr 10TCr 63TCr 24TCr 2,88900Cr 25TCr 25TCr 10,54400Cr | EV / Sales 2026 * |
4.23x | EV / Sales 2027 * | 3.99x |
| Free-Float |
99.9% | Yield 2026 * |
2.53% | Yield 2027 * | 2.75% |
Last Transcript: CSL Limited
| 1 day | -0.94% | ||
| 1 week | -1.77% | ||
| Current month | -2.20% | ||
| 1 month | +0.22% | ||
| 3 months | -10.89% | ||
| 6 months | -23.79% | ||
| Current year | -35.29% |
| 1 week | 178.12 | 186.5 | |
| 1 month | 175.77 | 188.67 | |
| Current year | 168 | 290.32 | |
| 1 year | 168 | 290.32 | |
| 3 years | 168 | 314.28 | |
| 5 years | 168 | 319.78 | |
| 10 years | 91.62 | 342.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul McKenzie
CEO | Chief Executive Officer | 59 | 06/03/2023 |
Ken Lim
DFI | Director of Finance/CFO | 51 | 07/10/2025 |
Mark Hill
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/10/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 71 | 17/10/2018 | |
Marie McDonald
BRD | Director/Board Member | 69 | 14/08/2013 |
Megan Clark
BRD | Director/Board Member | 67 | 16/02/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | -1.77% | -34.17% | -39.12% | 5.89TCr | ||
| -0.74% | +3.19% | +1.37% | -0.84% | 7.61TCr | ||
| +1.38% | +69.20% | +69.20% | +69.20% | 5.3TCr | ||
| -2.24% | -4.93% | +30.25% | +221.80% | 5.25TCr | ||
| +0.93% | -3.97% | +16.04% | -40.22% | 2.55TCr | ||
| +1.85% | -7.39% | +127.81% | +163.37% | 1.88TCr | ||
| -0.72% | -6.94% | +39.18% | +15.08% | 1.87TCr | ||
| -4.52% | -5.15% | +36.59% | +1,036.48% | 1.57TCr | ||
| +1.46% | +2.05% | +173.37% | +704.60% | 1.45TCr | ||
| -0.04% | -.--% | +58.82% | +142.19% | 1.4TCr | ||
| Average | -0.36% | -1.97% | +51.85% | +227.25% | 3.48TCr | |
| Weighted average by Cap. | -0.46% | -0.70% | +31.05% | +125.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.6TCr 1.36TCr 1.27TCr 1.2TCr 2.2TCr 1,44900Cr 2.41TCr 15TCr 5.76TCr 68TCr 6TCr 5.88TCr 2,49300Cr | 1.67TCr 1.43TCr 1.33TCr 1.25TCr 2.3TCr 1,51600Cr 2.52TCr 15TCr 6.02TCr 71TCr 6.28TCr 6.15TCr 2,60800Cr |
| Net income | 257.86Cr 219.65Cr 205.15Cr 192.88Cr 354.96Cr 23TCr 387.8Cr 2.39TCr 927.37Cr 11TCr 967.61Cr 946.9Cr 40TCr | 343.13Cr 292.3Cr 272.99Cr 256.66Cr 472.36Cr 31TCr 516.05Cr 3.18TCr 1.23TCr 15TCr 1.29TCr 1.26TCr 53TCr |
| Net Debt | 876.03Cr 746.24Cr 696.96Cr 655.27Cr 1.21TCr 79TCr 1.32TCr 8.11TCr 3.15TCr 37TCr 3.29TCr 3.22TCr 1,36500Cr | 784.82Cr 668.54Cr 624.39Cr 587.04Cr 1.08TCr 71TCr 1.18TCr 7.26TCr 2.82TCr 34TCr 2.95TCr 2.88TCr 1,22300Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/25/15 | 182.12 $ | -0.99% | 56,209 |
| 12/25/12 | 183.93 $ | +2.86% | 9,73,901 |
| 11/25/11 | 178.81 $ | -1.55% | 8,55,310 |
| 10/25/10 | 181.63 $ | -0.10% | 6,93,730 |
| 09/25/09 | 181.82 $ | -1.98% | 8,78,270 |
Delayed Quote Australian S.E., December 15, 2025 at 04:44 am IST
More quotesTrader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- CSL Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















